At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Vivaer Stylusdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus
In Brief
A clinical study evaluating Vivaer Stylus for Nasal Obstruction. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study evaluates subjective and objective measures of treatment outcome after using the Aerin Medical Vivaer™ Stylus to treat nasal obstruction
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Obstruction
CountriesUnited States
CollaboratorsOhio State University
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartSep 2017
Primary CompletionJul 2019
Study CompletionAug 2019
TodayJul 2026
First PostedMay 17, 2017
Enrollment StartSep 19, 2017
Primary CompletionJul 12, 2019
Study CompletionAug 6, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.1 years ago
Interventions
Vivaer Stylusdevice
Stylus used to deliver low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area